Global Antibody Drug Conjugate (ADC) Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Antibody Drug Conjugate (ADC) Drug Industry Forecast” looks at past sales and reviews total world Antibody Drug Conjugate (ADC) Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody Drug Conjugate (ADC) Drug sales for 2023 through 2029. With Antibody Drug Conjugate (ADC) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drug Conjugate (ADC) Drug industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drug Conjugate (ADC) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drug Conjugate (ADC) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Drug Conjugate (ADC) Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drug Conjugate (ADC) Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drug Conjugate (ADC) Drug.
The global Antibody Drug Conjugate (ADC) Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibody Drug Conjugate (ADC) Drug players cover Oxford Bio Therapeutics, Synthon, Progenics Pharmaceuticals, Bayer HealthCare, Millennium Pharmaceuticals, Pfizer, Concortis Bio therapeutics, Roche Holding AG and Seattle Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate (ADC) Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Antibody Drug Conjugate (ADC) Drug Industry Forecast” looks at past sales and reviews total world Antibody Drug Conjugate (ADC) Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibody Drug Conjugate (ADC) Drug sales for 2023 through 2029. With Antibody Drug Conjugate (ADC) Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Drug Conjugate (ADC) Drug industry.
This Insight Report provides a comprehensive analysis of the global Antibody Drug Conjugate (ADC) Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Drug Conjugate (ADC) Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Drug Conjugate (ADC) Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Drug Conjugate (ADC) Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Drug Conjugate (ADC) Drug.
The global Antibody Drug Conjugate (ADC) Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibody Drug Conjugate (ADC) Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibody Drug Conjugate (ADC) Drug players cover Oxford Bio Therapeutics, Synthon, Progenics Pharmaceuticals, Bayer HealthCare, Millennium Pharmaceuticals, Pfizer, Concortis Bio therapeutics, Roche Holding AG and Seattle Genetics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate (ADC) Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- by Technology
- Mmunomedics Technology
- Immunogen Technology
- Seattle Genetics Technology
- Others
- by Product Type
- Kadcyla
- Adcertis
- Biotechnology Companies
- Specialized Cancer Centers
- Biopharmaceutical Companies
- Academic Research Institutes
- Hospitals
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Oxford Bio Therapeutics
- Synthon
- Progenics Pharmaceuticals
- Bayer HealthCare
- Millennium Pharmaceuticals
- Pfizer
- Concortis Bio therapeutics
- Roche Holding AG
- Seattle Genetics
- Heidelberg Pharma
- Mersana Therapeutics
- Astellas Pharma/Agensys
- AbbVie Inc
- Celldex Therapeutics
- Immunomedics
- Agensys
- Genentech
- ImmunoGen
- Sanofi
- Genmab
- Amgen
- Novartis
- Eli Lilly
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate (ADC) Drug Market Size 2018-2029
2.1.2 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Antibody Drug Conjugate (ADC) Drug Segment by Type
2.2.1 Mmunomedics Technology
2.2.2 Immunogen Technology
2.2.3 Seattle Genetics Technology
2.2.4 Others
2.3 Antibody Drug Conjugate (ADC) Drug Market Size by Type
2.3.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
2.4 Antibody Drug Conjugate (ADC) Drug Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Specialized Cancer Centers
2.4.3 Biopharmaceutical Companies
2.4.4 Academic Research Institutes
2.4.5 Hospitals
2.4.6 Others
2.5 Antibody Drug Conjugate (ADC) Drug Market Size by Application
2.5.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
3 ANTIBODY DRUG CONJUGATE (ADC) DRUG MARKET SIZE BY PLAYER
3.1 Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2018-2023)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2018-2023)
3.2 Global Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIBODY DRUG CONJUGATE (ADC) DRUG BY REGIONS
4.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions (2018-2023)
4.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023)
5.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
5.3 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023)
6.2 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
6.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antibody Drug Conjugate (ADC) Drug by Country (2018-2023)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug by Region (2018-2023)
8.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIBODY DRUG CONJUGATE (ADC) DRUG MARKET FORECAST
10.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2024-2029)
10.1.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2024-2029)
10.1.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast
10.1.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast
10.1.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast
10.1.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast
10.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast by Country (2024-2029)
10.2.1 United States Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.2 Canada Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.3 Mexico Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.4 Brazil Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast by Region (2024-2029)
10.3.1 China Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.2 Japan Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.3 Korea Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.4 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.5 India Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.6 Australia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast by Country (2024-2029)
10.4.1 Germany Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.2 France Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.3 UK Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.4 Italy Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.5 Russia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast by Region (2024-2029)
10.5.1 Egypt Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.2 South Africa Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.3 Israel Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.4 Turkey Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.5 GCC Countries Antibody Drug Conjugate (ADC) Drug Market Forecast
10.6 Global Antibody Drug Conjugate (ADC) Drug Forecast by Type (2024-2029)
10.7 Global Antibody Drug Conjugate (ADC) Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Information
11.1.2 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Oxford Bio Therapeutics Main Business Overview
11.1.5 Oxford Bio Therapeutics Latest Developments
11.2 Synthon
11.2.1 Synthon Company Information
11.2.2 Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Synthon Main Business Overview
11.2.5 Synthon Latest Developments
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Information
11.3.2 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Progenics Pharmaceuticals Main Business Overview
11.3.5 Progenics Pharmaceuticals Latest Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Information
11.4.2 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer HealthCare Main Business Overview
11.4.5 Bayer HealthCare Latest Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Information
11.5.2 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Millennium Pharmaceuticals Main Business Overview
11.5.5 Millennium Pharmaceuticals Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Information
11.7.2 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Concortis Bio therapeutics Main Business Overview
11.7.5 Concortis Bio therapeutics Latest Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Holding AG Main Business Overview
11.8.5 Roche Holding AG Latest Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Information
11.9.2 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Seattle Genetics Main Business Overview
11.9.5 Seattle Genetics Latest Developments
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Information
11.10.2 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Heidelberg Pharma Main Business Overview
11.10.5 Heidelberg Pharma Latest Developments
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Information
11.11.2 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Mersana Therapeutics Main Business Overview
11.11.5 Mersana Therapeutics Latest Developments
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Information
11.12.2 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astellas Pharma/Agensys Main Business Overview
11.12.5 Astellas Pharma/Agensys Latest Developments
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Information
11.13.2 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 AbbVie Inc Main Business Overview
11.13.5 AbbVie Inc Latest Developments
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Information
11.14.2 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Celldex Therapeutics Main Business Overview
11.14.5 Celldex Therapeutics Latest Developments
11.15 Immunomedics
11.15.1 Immunomedics Company Information
11.15.2 Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Immunomedics Main Business Overview
11.15.5 Immunomedics Latest Developments
11.16 Agensys
11.16.1 Agensys Company Information
11.16.2 Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Agensys Main Business Overview
11.16.5 Agensys Latest Developments
11.17 Genentech
11.17.1 Genentech Company Information
11.17.2 Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Genentech Main Business Overview
11.17.5 Genentech Latest Developments
11.18 ImmunoGen
11.18.1 ImmunoGen Company Information
11.18.2 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 ImmunoGen Main Business Overview
11.18.5 ImmunoGen Latest Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Sanofi Main Business Overview
11.19.5 Sanofi Latest Developments
11.20 Genmab
11.20.1 Genmab Company Information
11.20.2 Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Genmab Main Business Overview
11.20.5 Genmab Latest Developments
11.21 Amgen
11.21.1 Amgen Company Information
11.21.2 Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Amgen Main Business Overview
11.21.5 Amgen Latest Developments
11.22 Novartis
11.22.1 Novartis Company Information
11.22.2 Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Novartis Main Business Overview
11.22.5 Novartis Latest Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Information
11.23.2 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Eli Lilly Main Business Overview
11.23.5 Eli Lilly Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate (ADC) Drug Market Size 2018-2029
2.1.2 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Antibody Drug Conjugate (ADC) Drug Segment by Type
2.2.1 Mmunomedics Technology
2.2.2 Immunogen Technology
2.2.3 Seattle Genetics Technology
2.2.4 Others
2.3 Antibody Drug Conjugate (ADC) Drug Market Size by Type
2.3.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
2.4 Antibody Drug Conjugate (ADC) Drug Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Specialized Cancer Centers
2.4.3 Biopharmaceutical Companies
2.4.4 Academic Research Institutes
2.4.5 Hospitals
2.4.6 Others
2.5 Antibody Drug Conjugate (ADC) Drug Market Size by Application
2.5.1 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
3 ANTIBODY DRUG CONJUGATE (ADC) DRUG MARKET SIZE BY PLAYER
3.1 Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2018-2023)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2018-2023)
3.2 Global Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ANTIBODY DRUG CONJUGATE (ADC) DRUG BY REGIONS
4.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions (2018-2023)
4.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023)
5.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
5.3 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023)
6.2 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
6.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Antibody Drug Conjugate (ADC) Drug by Country (2018-2023)
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug by Region (2018-2023)
8.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ANTIBODY DRUG CONJUGATE (ADC) DRUG MARKET FORECAST
10.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2024-2029)
10.1.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2024-2029)
10.1.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast
10.1.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast
10.1.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast
10.1.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast
10.2 Americas Antibody Drug Conjugate (ADC) Drug Forecast by Country (2024-2029)
10.2.1 United States Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.2 Canada Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.3 Mexico Antibody Drug Conjugate (ADC) Drug Market Forecast
10.2.4 Brazil Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3 APAC Antibody Drug Conjugate (ADC) Drug Forecast by Region (2024-2029)
10.3.1 China Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.2 Japan Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.3 Korea Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.4 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.5 India Antibody Drug Conjugate (ADC) Drug Market Forecast
10.3.6 Australia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4 Europe Antibody Drug Conjugate (ADC) Drug Forecast by Country (2024-2029)
10.4.1 Germany Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.2 France Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.3 UK Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.4 Italy Antibody Drug Conjugate (ADC) Drug Market Forecast
10.4.5 Russia Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Forecast by Region (2024-2029)
10.5.1 Egypt Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.2 South Africa Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.3 Israel Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.4 Turkey Antibody Drug Conjugate (ADC) Drug Market Forecast
10.5.5 GCC Countries Antibody Drug Conjugate (ADC) Drug Market Forecast
10.6 Global Antibody Drug Conjugate (ADC) Drug Forecast by Type (2024-2029)
10.7 Global Antibody Drug Conjugate (ADC) Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Oxford Bio Therapeutics
11.1.1 Oxford Bio Therapeutics Company Information
11.1.2 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Oxford Bio Therapeutics Main Business Overview
11.1.5 Oxford Bio Therapeutics Latest Developments
11.2 Synthon
11.2.1 Synthon Company Information
11.2.2 Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
11.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Synthon Main Business Overview
11.2.5 Synthon Latest Developments
11.3 Progenics Pharmaceuticals
11.3.1 Progenics Pharmaceuticals Company Information
11.3.2 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Progenics Pharmaceuticals Main Business Overview
11.3.5 Progenics Pharmaceuticals Latest Developments
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Information
11.4.2 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer HealthCare Main Business Overview
11.4.5 Bayer HealthCare Latest Developments
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Information
11.5.2 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Millennium Pharmaceuticals Main Business Overview
11.5.5 Millennium Pharmaceuticals Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
11.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Concortis Bio therapeutics
11.7.1 Concortis Bio therapeutics Company Information
11.7.2 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Concortis Bio therapeutics Main Business Overview
11.7.5 Concortis Bio therapeutics Latest Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
11.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Holding AG Main Business Overview
11.8.5 Roche Holding AG Latest Developments
11.9 Seattle Genetics
11.9.1 Seattle Genetics Company Information
11.9.2 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Seattle Genetics Main Business Overview
11.9.5 Seattle Genetics Latest Developments
11.10 Heidelberg Pharma
11.10.1 Heidelberg Pharma Company Information
11.10.2 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
11.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Heidelberg Pharma Main Business Overview
11.10.5 Heidelberg Pharma Latest Developments
11.11 Mersana Therapeutics
11.11.1 Mersana Therapeutics Company Information
11.11.2 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Mersana Therapeutics Main Business Overview
11.11.5 Mersana Therapeutics Latest Developments
11.12 Astellas Pharma/Agensys
11.12.1 Astellas Pharma/Agensys Company Information
11.12.2 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astellas Pharma/Agensys Main Business Overview
11.12.5 Astellas Pharma/Agensys Latest Developments
11.13 AbbVie Inc
11.13.1 AbbVie Inc Company Information
11.13.2 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
11.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 AbbVie Inc Main Business Overview
11.13.5 AbbVie Inc Latest Developments
11.14 Celldex Therapeutics
11.14.1 Celldex Therapeutics Company Information
11.14.2 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
11.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Celldex Therapeutics Main Business Overview
11.14.5 Celldex Therapeutics Latest Developments
11.15 Immunomedics
11.15.1 Immunomedics Company Information
11.15.2 Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
11.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Immunomedics Main Business Overview
11.15.5 Immunomedics Latest Developments
11.16 Agensys
11.16.1 Agensys Company Information
11.16.2 Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
11.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Agensys Main Business Overview
11.16.5 Agensys Latest Developments
11.17 Genentech
11.17.1 Genentech Company Information
11.17.2 Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
11.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Genentech Main Business Overview
11.17.5 Genentech Latest Developments
11.18 ImmunoGen
11.18.1 ImmunoGen Company Information
11.18.2 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
11.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 ImmunoGen Main Business Overview
11.18.5 ImmunoGen Latest Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
11.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Sanofi Main Business Overview
11.19.5 Sanofi Latest Developments
11.20 Genmab
11.20.1 Genmab Company Information
11.20.2 Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
11.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Genmab Main Business Overview
11.20.5 Genmab Latest Developments
11.21 Amgen
11.21.1 Amgen Company Information
11.21.2 Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
11.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Amgen Main Business Overview
11.21.5 Amgen Latest Developments
11.22 Novartis
11.22.1 Novartis Company Information
11.22.2 Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
11.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Novartis Main Business Overview
11.22.5 Novartis Latest Developments
11.23 Eli Lilly
11.23.1 Eli Lilly Company Information
11.23.2 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
11.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Eli Lilly Main Business Overview
11.23.5 Eli Lilly Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Mmunomedics Technology
Table 3. Major Players of Immunogen Technology
Table 4. Major Players of Seattle Genetics Technology
Table 5. Major Players of Others
Table 6. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 9. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player (2018-2023)
Table 14. Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
Table 15. Antibody Drug Conjugate (ADC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Antibody Drug Conjugate (ADC) Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate (ADC) Drug
Table 47. Key Market Challenges & Risks of Antibody Drug Conjugate (ADC) Drug
Table 48. Key Industry Trends of Antibody Drug Conjugate (ADC) Drug
Table 49. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Oxford Bio Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 54. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 55. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Oxford Bio Therapeutics Main Business
Table 57. Oxford Bio Therapeutics Latest Developments
Table 58. Synthon Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 59. Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
Table 60. Synthon Main Business
Table 61. Synthon Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Synthon Latest Developments
Table 63. Progenics Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 64. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 65. Progenics Pharmaceuticals Main Business
Table 66. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Progenics Pharmaceuticals Latest Developments
Table 68. Bayer HealthCare Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 69. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
Table 70. Bayer HealthCare Main Business
Table 71. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Bayer HealthCare Latest Developments
Table 73. Millennium Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 74. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 75. Millennium Pharmaceuticals Main Business
Table 76. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Millennium Pharmaceuticals Latest Developments
Table 78. Pfizer Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 79. Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
Table 80. Pfizer Main Business
Table 81. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Pfizer Latest Developments
Table 83. Concortis Bio therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 84. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 85. Concortis Bio therapeutics Main Business
Table 86. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Concortis Bio therapeutics Latest Developments
Table 88. Roche Holding AG Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 89. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
Table 90. Roche Holding AG Main Business
Table 91. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Roche Holding AG Latest Developments
Table 93. Seattle Genetics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 94. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 95. Seattle Genetics Main Business
Table 96. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Seattle Genetics Latest Developments
Table 98. Heidelberg Pharma Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 99. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
Table 100. Heidelberg Pharma Main Business
Table 101. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Heidelberg Pharma Latest Developments
Table 103. Mersana Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 104. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 105. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Mersana Therapeutics Main Business
Table 107. Mersana Therapeutics Latest Developments
Table 108. Astellas Pharma/Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 109. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 110. Astellas Pharma/Agensys Main Business
Table 111. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Astellas Pharma/Agensys Latest Developments
Table 113. AbbVie Inc Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 114. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
Table 115. AbbVie Inc Main Business
Table 116. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. AbbVie Inc Latest Developments
Table 118. Celldex Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 119. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 120. Celldex Therapeutics Main Business
Table 121. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Celldex Therapeutics Latest Developments
Table 123. Immunomedics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 124. Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 125. Immunomedics Main Business
Table 126. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Immunomedics Latest Developments
Table 128. Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 129. Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 130. Agensys Main Business
Table 131. Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Agensys Latest Developments
Table 133. Genentech Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 134. Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
Table 135. Genentech Main Business
Table 136. Genentech Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Genentech Latest Developments
Table 138. ImmunoGen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 139. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 140. ImmunoGen Main Business
Table 141. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. ImmunoGen Latest Developments
Table 143. Sanofi Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 144. Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
Table 145. Sanofi Main Business
Table 146. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Sanofi Latest Developments
Table 148. Genmab Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 149. Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
Table 150. Genmab Main Business
Table 151. Genmab Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Genmab Latest Developments
Table 153. Amgen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 154. Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 155. Amgen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Amgen Main Business
Table 157. Amgen Latest Developments
Table 158. Novartis Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 159. Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
Table 160. Novartis Main Business
Table 161. Novartis Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 162. Novartis Latest Developments
Table 163. Eli Lilly Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 164. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
Table 165. Eli Lilly Main Business
Table 166. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 167. Eli Lilly Latest Developments
Table 1. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Mmunomedics Technology
Table 3. Major Players of Immunogen Technology
Table 4. Major Players of Seattle Genetics Technology
Table 5. Major Players of Others
Table 6. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 9. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 12. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player (2018-2023)
Table 14. Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
Table 15. Antibody Drug Conjugate (ADC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2018-2023)
Table 20. Global Antibody Drug Conjugate (ADC) Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2018-2023)
Table 24. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 26. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 28. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Table 30. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 32. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 34. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country (2018-2023)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 38. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate (ADC) Drug
Table 47. Key Market Challenges & Risks of Antibody Drug Conjugate (ADC) Drug
Table 48. Key Industry Trends of Antibody Drug Conjugate (ADC) Drug
Table 49. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Oxford Bio Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 54. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 55. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Oxford Bio Therapeutics Main Business
Table 57. Oxford Bio Therapeutics Latest Developments
Table 58. Synthon Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 59. Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
Table 60. Synthon Main Business
Table 61. Synthon Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Synthon Latest Developments
Table 63. Progenics Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 64. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 65. Progenics Pharmaceuticals Main Business
Table 66. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Progenics Pharmaceuticals Latest Developments
Table 68. Bayer HealthCare Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 69. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
Table 70. Bayer HealthCare Main Business
Table 71. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Bayer HealthCare Latest Developments
Table 73. Millennium Pharmaceuticals Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 74. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 75. Millennium Pharmaceuticals Main Business
Table 76. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Millennium Pharmaceuticals Latest Developments
Table 78. Pfizer Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 79. Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
Table 80. Pfizer Main Business
Table 81. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Pfizer Latest Developments
Table 83. Concortis Bio therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 84. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 85. Concortis Bio therapeutics Main Business
Table 86. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Concortis Bio therapeutics Latest Developments
Table 88. Roche Holding AG Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 89. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
Table 90. Roche Holding AG Main Business
Table 91. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Roche Holding AG Latest Developments
Table 93. Seattle Genetics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 94. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 95. Seattle Genetics Main Business
Table 96. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Seattle Genetics Latest Developments
Table 98. Heidelberg Pharma Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 99. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
Table 100. Heidelberg Pharma Main Business
Table 101. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Heidelberg Pharma Latest Developments
Table 103. Mersana Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 104. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 105. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Mersana Therapeutics Main Business
Table 107. Mersana Therapeutics Latest Developments
Table 108. Astellas Pharma/Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 109. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 110. Astellas Pharma/Agensys Main Business
Table 111. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Astellas Pharma/Agensys Latest Developments
Table 113. AbbVie Inc Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 114. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product Offered
Table 115. AbbVie Inc Main Business
Table 116. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. AbbVie Inc Latest Developments
Table 118. Celldex Therapeutics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 119. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 120. Celldex Therapeutics Main Business
Table 121. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Celldex Therapeutics Latest Developments
Table 123. Immunomedics Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 124. Immunomedics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 125. Immunomedics Main Business
Table 126. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Immunomedics Latest Developments
Table 128. Agensys Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 129. Agensys Antibody Drug Conjugate (ADC) Drug Product Offered
Table 130. Agensys Main Business
Table 131. Agensys Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Agensys Latest Developments
Table 133. Genentech Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 134. Genentech Antibody Drug Conjugate (ADC) Drug Product Offered
Table 135. Genentech Main Business
Table 136. Genentech Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Genentech Latest Developments
Table 138. ImmunoGen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 139. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 140. ImmunoGen Main Business
Table 141. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. ImmunoGen Latest Developments
Table 143. Sanofi Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 144. Sanofi Antibody Drug Conjugate (ADC) Drug Product Offered
Table 145. Sanofi Main Business
Table 146. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Sanofi Latest Developments
Table 148. Genmab Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 149. Genmab Antibody Drug Conjugate (ADC) Drug Product Offered
Table 150. Genmab Main Business
Table 151. Genmab Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. Genmab Latest Developments
Table 153. Amgen Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 154. Amgen Antibody Drug Conjugate (ADC) Drug Product Offered
Table 155. Amgen Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 156. Amgen Main Business
Table 157. Amgen Latest Developments
Table 158. Novartis Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 159. Novartis Antibody Drug Conjugate (ADC) Drug Product Offered
Table 160. Novartis Main Business
Table 161. Novartis Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 162. Novartis Latest Developments
Table 163. Eli Lilly Details, Company Type, Antibody Drug Conjugate (ADC) Drug Area Served and Its Competitors
Table 164. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product Offered
Table 165. Eli Lilly Main Business
Table 166. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 167. Eli Lilly Latest Developments
LIST OF FIGURES
Figure 1. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Antibody Drug Conjugate (ADC) Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Antibody Drug Conjugate (ADC) Drug Sales Market Share by Country/Region (2022)
Figure 8. Antibody Drug Conjugate (ADC) Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2022
Figure 10. Antibody Drug Conjugate (ADC) Drug in Biotechnology Companies
Figure 11. Global Antibody Drug Conjugate (ADC) Drug Market: Biotechnology Companies (2018-2023) & ($ Millions)
Figure 12. Antibody Drug Conjugate (ADC) Drug in Specialized Cancer Centers
Figure 13. Global Antibody Drug Conjugate (ADC) Drug Market: Specialized Cancer Centers (2018-2023) & ($ Millions)
Figure 14. Antibody Drug Conjugate (ADC) Drug in Biopharmaceutical Companies
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market: Biopharmaceutical Companies (2018-2023) & ($ Millions)
Figure 16. Antibody Drug Conjugate (ADC) Drug in Academic Research Institutes
Figure 17. Global Antibody Drug Conjugate (ADC) Drug Market: Academic Research Institutes (2018-2023) & ($ Millions)
Figure 18. Antibody Drug Conjugate (ADC) Drug in Hospitals
Figure 19. Global Antibody Drug Conjugate (ADC) Drug Market: Hospitals (2018-2023) & ($ Millions)
Figure 20. Antibody Drug Conjugate (ADC) Drug in Others
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Market: Others (2018-2023) & ($ Millions)
Figure 22. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2022
Figure 23. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player in 2022
Figure 24. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 26. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 27. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 29. Americas Antibody Drug Conjugate (ADC) Drug Value Market Share by Country in 2022
Figure 30. United States Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region in 2022
Figure 35. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2022
Figure 36. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2022
Figure 37. China Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country in 2022
Figure 44. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Figure 45. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Figure 46. Germany Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 60. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 61. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 63. United States Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 64. Canada Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 67. China Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 68. Japan Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 69. Korea Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 71. India Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 72. Australia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 73. Germany Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 74. France Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 75. UK Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 76. Italy Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 77. Russia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 78. Spain Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 81. Israel Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 84. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Antibody Drug Conjugate (ADC) Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Antibody Drug Conjugate (ADC) Drug Sales Market Share by Country/Region (2022)
Figure 8. Antibody Drug Conjugate (ADC) Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2022
Figure 10. Antibody Drug Conjugate (ADC) Drug in Biotechnology Companies
Figure 11. Global Antibody Drug Conjugate (ADC) Drug Market: Biotechnology Companies (2018-2023) & ($ Millions)
Figure 12. Antibody Drug Conjugate (ADC) Drug in Specialized Cancer Centers
Figure 13. Global Antibody Drug Conjugate (ADC) Drug Market: Specialized Cancer Centers (2018-2023) & ($ Millions)
Figure 14. Antibody Drug Conjugate (ADC) Drug in Biopharmaceutical Companies
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market: Biopharmaceutical Companies (2018-2023) & ($ Millions)
Figure 16. Antibody Drug Conjugate (ADC) Drug in Academic Research Institutes
Figure 17. Global Antibody Drug Conjugate (ADC) Drug Market: Academic Research Institutes (2018-2023) & ($ Millions)
Figure 18. Antibody Drug Conjugate (ADC) Drug in Hospitals
Figure 19. Global Antibody Drug Conjugate (ADC) Drug Market: Hospitals (2018-2023) & ($ Millions)
Figure 20. Antibody Drug Conjugate (ADC) Drug in Others
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Market: Others (2018-2023) & ($ Millions)
Figure 22. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2022
Figure 23. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Player in 2022
Figure 24. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 26. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 27. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2018-2023 ($ Millions)
Figure 29. Americas Antibody Drug Conjugate (ADC) Drug Value Market Share by Country in 2022
Figure 30. United States Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region in 2022
Figure 35. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2022
Figure 36. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2022
Figure 37. China Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Country in 2022
Figure 44. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Figure 45. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Figure 46. Germany Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Antibody Drug Conjugate (ADC) Drug Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 60. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 61. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 63. United States Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 64. Canada Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 67. China Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 68. Japan Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 69. Korea Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 71. India Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 72. Australia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 73. Germany Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 74. France Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 75. UK Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 76. Italy Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 77. Russia Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 78. Spain Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 81. Israel Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Antibody Drug Conjugate (ADC) Drug Market Size 2024-2029 ($ Millions)
Figure 84. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Application (2024-2029)
